Critical Pressure
Cambridge
About Critical Pressure
Critical Pressure is a provider of drugs designed to treat to treat vascular dysfunction and shock. The company's technology has the potential to change clinical practice without the potentially harmful effects of excess fluid administration and toxicities associated with the currently available catecholamine-based vasoactive agents, providing the possibility of supportive therapy during the critical period of haemodynamic compromise.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2017)
- Website: critical-pressure.com
- Phone: +44 (0)1223 834510
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Virtual Reality
Social Profiles
Canonical: https://fsome.com/organization/critical-pressure-76063 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.